retatrutide phase 2 study results just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Lilly's triple agonist delivers up

At the extreme end, adherents lengthen their legs by breaking their bones, undergo bimaxillary osteotomies (double jaw surgery), and imbibe peptides that pledge to augment your brainpower and suppress your appetite

Increased Heart Rate: An elevated heart rate is a possible side effect if you have existing heart conditions

[137] [138] High demand caused worldwide supply shortages of semaglutide in 2023

The primary concern is peptide denaturation, where elevated temperatures disrupt the hydrogen bonds and hydrophobic interactions that maintain the peptide's active three-dimensional structure

Patients and clinicians should be aware that reflux-type symptoms are biologically plausible and have been reported in trial settings for this drug class, even if a definitive causal link has not been formally established for retatrutide specifically